Paladin Advisory Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,688
Closed -$141K 366
2022
Q4
$141K Hold
2,688
0.12% 109
2022
Q3
$126K Hold
2,688
0.12% 109
2022
Q2
$135K Buy
+2,688
New +$147K 0.12% 110
2022
Q1
Sell
-2,688
Closed -$177K 379
2021
Q4
$177K Buy
+2,688
New +$172K 0.14% 102

Other funds holding IHI

Paladin Advisory Group's IHI Position: Q3 2025 in Review

Paladin Advisory Group sold out of iShares US Medical Devices ETF (IHI) in Q3 2025, closing a stake of 1,020 shares — an estimated $63.9K sold.

Paladin Advisory Group first reported a position in IHI in Q1 2022 and held it in 11 quarters. The position peaked at $165K in Q1 2022. 525 funds tracked by Wall St. Rank hold IHI as of Q3 2025.

  • Paladin Advisory Group reported no remaining iShares US Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
  • Paladin Advisory Group sold 1,020 iShares US Medical Devices ETF shares in Q3 2025, an estimated $63.9K.
  • Paladin Advisory Group first reported a position in iShares US Medical Devices ETF in Q1 2022 and held it in 11 quarters.
  • Paladin Advisory Group's iShares US Medical Devices ETF position peaked at $165K in Q1 2022.
  • 525 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2025.

Based on Paladin Advisory Group's 13F filing for Q3 2025, filed 5 Nov 2025.